Published in Cell Mol Life Sci on September 01, 2007
DNA vaccines: developing new strategies against cancer. J Biomed Biotechnol (2010) 1.12
Vaccines and immunotherapeutics for the treatment of malignant disease. Clin Dev Immunol (2010) 1.04
Tumor immunity against a simian virus 40 oncoprotein requires CD8+ T lymphocytes in the effector immune phase. J Virol (2009) 0.89
DNA plasmid production in different host strains of Escherichia coli. J Ind Microbiol Biotechnol (2009) 0.87
DNA vaccine for cancer immunotherapy. Hum Vaccin Immunother (2014) 0.87
An artificial PAP gene breaks self-tolerance and promotes tumor regression in the TRAMP model for prostate carcinoma. Mol Ther (2011) 0.80
TAA polyepitope DNA-based vaccines: a potential tool for cancer therapy. J Biomed Biotechnol (2010) 0.79
Role of the innate immune response and tumor immunity associated with simian virus 40 large tumor antigen. J Virol (2010) 0.78
CD4+ T lymphocytes are critical mediators of tumor immunity to simian virus 40 large tumor antigen induced by vaccination with plasmid DNA. J Virol (2011) 0.77
A DNA adjuvant encoding a fusion protein between anti-CD3 single-chain Fv and AIMP1 enhances T helper type 1 cell-mediated immune responses in antigen-sensitized mice. Immunology (2008) 0.75
A microfluidic approach towards hybridoma generation for cancer immunotherapy. Oncotarget (2015) 0.75
Human immunodeficiency virus neutralizing antibodies recognize several conserved domains on the envelope glycoproteins. J Virol (1987) 5.03
Induction of nuclear transport with a synthetic peptide homologous to the SV40 T antigen transport signal. Cell (1986) 4.56
Induction of anti-HIV neutralizing antibodies by synthetic peptides. EMBO J (1986) 4.32
Natural infection of Suffolk sheep with scrapie virus. J Infect Dis (1982) 3.42
Pathogenesis of scrapie virus infection in the mouse. J Infect Dis (1967) 3.34
Aleutian disease of mink: properties of the etiologic agent and the host responses. J Infect Dis (1968) 3.03
Antiserum to a synthetic peptide recognizes the HTLV-III envelope glycoprotein. Science (1986) 2.33
Neutralization of diverse HIV-1 strains by monoclonal antibodies raised against a gp41 synthetic peptide. Virology (1988) 2.05
Virologic and neurohistologic findings in dairy goats affected with natural scrapie. Vet Pathol (1980) 1.88
Comparative pathogenicity of four strains of Aleutian disease virus for pastel and sapphire mink. Infect Immun (1983) 1.77
Characterization of PEDF: a multi-functional serpin family protein. J Cell Biochem (2009) 1.77
Correlation between the prevalence of certain fungi and sick building syndrome. Occup Environ Med (1998) 1.68
Bacterial determinants of persistent throat colonization and the associated immune response in a primate model of human group A streptococcal pharyngeal infection. Cell Microbiol (2000) 1.49
Immune response to hepatitis B surface antigen: enhancement by prior injection of antibodies to the idiotype. Science (1983) 1.48
Isolation of a virus from the lungs of Montana sheep affected with progressive pneumonia. Virology (1968) 1.46
Obstetric fistula in rural Ethiopia. East Afr Med J (2007) 1.38
Common idiotypic determinant associated with human antibodies to hepatitis B surface antigen. J Immunol (1983) 1.38
Biotin-avidin-amplified enzyme immunoassay for detection of herpes simplex virus antigen in clinical specimens. J Clin Microbiol (1983) 1.36
Course of experimental scrapie virus infection in the goat. J Infect Dis (1974) 1.36
Enhancement of the immune response to hepatitis B surface antigen. In vivo administration of antiidiotype induces anti-HBs that expresses a similar idiotype. J Exp Med (1984) 1.35
Isolation and characterization of simian immunodeficiency viruses from two subspecies of African green monkeys. AIDS Res Hum Retroviruses (1990) 1.29
Relation of the Escherichia coli dnaX gene to its two products--the tau and gamma subunits of DNA polymerase III holoenzyme. Nucleic Acids Res (1987) 1.25
A bactericidal antibody to Borrelia burgdorferi is directed against a variable region of the OspB protein. Infect Immun (1994) 1.24
Anti-idiotypic antibody vaccine for type B viral hepatitis in chimpanzees. Science (1986) 1.24
Comparison and characterization of immunoglobulin G subclasses among primate species. Clin Diagn Lab Immunol (1999) 1.21
Application of a modified computer algorithm in determining potential antigenic determinants associated with the AIDS virus glycoprotein. Anal Biochem (1985) 1.15
Nonhuman primate models to evaluate vaccine safety and immunogenicity. Vaccine (1997) 1.14
The sera of patients with Klebsiella infections contain a common anti-DNA idiotype (16/6) Id and anti-polynucleotide activity. Clin Exp Immunol (1987) 1.12
Induction of an anti-hepatitis B surface antigen response in mice by noninternal image (Ab2 alpha) anti-idiotypic antibodies. J Immunol (1987) 1.11
Regulation of capsule gene expression by group A Streptococcus during pharyngeal colonization and invasive infection. Mol Microbiol (2001) 1.10
Temporal distribution of transmissible mink encephalopathy virus in mink inoculated subcutaneously. J Virol (1987) 1.08
Antibody to hepatitis B virus induced by injecting antibodies to the idiotype. Science (1984) 1.08
Use of a resin-bound synthetic peptide for identifying a neutralizing antigenic determinant associated with the human immunodeficiency virus envelope. J Biol Chem (1987) 1.07
Effect of chlorine dioxide gas on fungi and mycotoxins associated with sick building syndrome. Appl Environ Microbiol (2005) 1.05
The detection of a common idiotype of anti-DNA antibodies in the sera of patients with monoclonal gammopathies. J Clin Immunol (1986) 1.04
Royal pastel mink respond variously to inoculation with Aleutian disease virus of low virulence. J Virol (1984) 1.04
Monoclonal anti-idiotypic antibody mimics the CD4 receptor and binds human immunodeficiency virus. Proc Natl Acad Sci U S A (1987) 1.03
Expression and immunogenicity of an 18-residue epitope of HIV1 gp41 inserted in the flagellar protein of a Salmonella live vaccine. Res Microbiol (1995) 1.03
HIV-1 gp120 proteins and gp160 peptides are toxic to brain endothelial cells and neurons: possible pathway for HIV entry into the brain and HIV-associated dementia. J Neuropathol Exp Neurol (2002) 1.03
A chemically defined liquid medium that supports primary isolation of Rochalimaea (Bartonella) henselae from blood and tissue specimens. J Clin Microbiol (1995) 1.03
Epitopes associated with a synthetic hepatitis B surface antigen peptide. J Immunol (1983) 1.02
Detection of interspecies idiotypic cross-reactions associated with antibodies to hepatitis B surface antigen. Eur J Immunol (1983) 1.02
A common anti-DNA idiotype in sera of patients with active pulmonary tuberculosis. Arthritis Rheum (1987) 1.01
Production and characterization of anti-idiotype reagents for the analysis of viral antigen systems. J Virol Methods (1983) 1.01
Resistance of previously infected chimpanzees to successive challenges with a heterologous intraclade B strain of human immunodeficiency virus type 1. J Virol (1996) 1.01
Expression and characterization of hepatitis B virus surface antigen polypeptides in insect cells with a baculovirus expression system. J Virol (1989) 1.01
Suppression of in vivo tumor formation induced by simian virus 40-transformed cells in mice receiving antiidiotypic antibodies. J Exp Med (1985) 0.99
Anti-idiotypic antibodies: implications of internal image-based vaccines for infectious diseases. J Infect Dis (1985) 0.98
Structural characterization of viral neutralizing monoclonal antibodies to hepatitis B surface antigen. Mol Immunol (1998) 0.98
Anti-idiotypic antibodies as immunogens: idiotype-based vaccines. Vaccine (1988) 0.97
Synthetic peptides define the fine specificity of the human immunodeficiency virus (HIV) gp160 humoral immune response in HIV type 1-infected chimpanzees. J Virol (1990) 0.96
Adenovirus keratitis: a role for interleukin-8. Invest Ophthalmol Vis Sci (2000) 0.96
HIV-induced syncytia of a T cell line form single giant pseudopods and are motile. J Cell Sci (1993) 0.96
T cell syncytia induced by HIV release. T cell chemoattractants: demonstration with a newly developed single cell chemotaxis chamber. J Cell Sci (1998) 0.96
Nuclei number in human embryos co-cultured with human ampullary cells. Hum Reprod (1996) 0.96
Longitudinal analysis of the humoral immune response to human immunodeficiency virus type 1 (HIV-1) gp160 epitopes in rapidly progressing and nonprogressing HIV-1-infected subjects. J Infect Dis (1993) 0.96
Characteristics of a shared idiotype by two IgM anti-herpes simplex virus monoclonal antibodies that recognize different determinants. J Immunol (1983) 0.94
Epidemiology of herpesvirus papio infection in a large captive baboon colony: similarities to Epstein-Barr virus infection in humans. J Infect Dis (2000) 0.94
Synthetic peptides homologous to HIV transmembrane glycoprotein suppress normal human lymphocyte blastogenic response. Cell Immunol (1988) 0.94
Maternal antibody transfer in baboons and mice vaccinated with a group B streptococcal polysaccharide conjugate. J Infect Dis (2000) 0.94
Protection against a lethal challenge with SV40-transformed cells by the direct injection of DNA-encoding SV40 large tumor antigen. Cancer Res (1996) 0.93
T cells and HIV-induced T cell syncytia exhibit the same motility cycle. J Leukoc Biol (1995) 0.93
Mode of action of a lysostaphin-like bacteriolytic agent produced by Streptococcus zooepidemicus 4881. Appl Environ Microbiol (1996) 0.92
Antiidiotype modulation of herpes simplex virus infection leading to increased pathogenicity. J Virol (1984) 0.92
Genetic vaccines. Sci Am (1999) 0.92
Experimental infection of sheep and goats with transmissible mink encephalopathy virus. Can J Vet Res (1987) 0.92
Temporal replication of the Pullman strain of Aleutian disease virus in royal pastel mink. J Virol (1985) 0.92
Analysis of human lung endothelial cells for susceptibility to HIV type 1 infection, coreceptor expression, and cytotoxicity of gp120 protein. AIDS Res Hum Retroviruses (2001) 0.92
Inhibition of normal human natural killer cell activity by human immunodeficiency virus synthetic transmembrane peptides. Cell Immunol (1988) 0.91
Immunogenicity of group B Streptococcus type III polysaccharide-tetanus toxoid vaccine in baboons. Infect Immun (1996) 0.91
Immune response to human immunodeficiency virus. In vivo administration of anti-idiotype induces an anti-gp160 response specific for a synthetic peptide. J Immunol (1987) 0.91
Synthetic peptides corresponding to sequences in HIV envelope gp41 and gp120 enhance in vitro production of interleukin-1 and tumor necrosis factor but depress production of interferon-alpha, interferon-gamma and interleukin-2. Viral Immunol (1991) 0.90
Patterns of antibody reactivity to selected human immunodeficiency virus type 1 (HIV-1) gp160 epitopes infected individuals grouped according to CD4+ cell levels. J Clin Immunol (1991) 0.90
Monoclonal anti-idiotypic antibodies induce humoral immune responses specific for simian virus 40 large tumor antigen in mice. J Immunol (1990) 0.90
Brain tissue from persons dying of Creutzfeldt-Jakob disease causes scrapie-like encephalopathy in goats. Ann Neurol (1980) 0.89
Analysis of nonhuman primate peripheral blood mononuclear cells for susceptibility to HIV-1 infection and HIV coreceptor expression. Dev Comp Immunol (1999) 0.89
The baboon as a nonhuman primate model for assessing the effects of maternal immunization with Haemophilus influenzae type b polysaccharide vaccines. Infect Immun (1997) 0.89
Administration of noninternal image monoclonal anti-idiotypic antibodies induces idiotype-restricted responses specific for human immunodeficiency virus envelope glycoprotein epitopes. Virology (1990) 0.88
Number of mitral cells and the bulb volume in the aging human olfactory bulb: a quantitative morphological study. Anat Rec (1987) 0.88
HIV-induced syncytia in peripheral blood cell cultures crawl by extending giant pseudopods. Cell Immunol (1995) 0.87
Comparative anatomy of mammalian conjunctival lymphoid tissue: a putative mucosal immune site. Dev Comp Immunol (1999) 0.87
Fetal immunization of baboons induces a fetal-specific antibody response. Nat Med (1999) 0.87
Sequential genital infections by herpes simplex viruses types 1 and 2: restriction nuclease analyses of viruses from recurrent infections. Sex Transm Dis (1984) 0.86
Synthesis of polyamide supports for use in peptide synthesis and as peptide-resin conjugates for antibody production. Int J Pept Protein Res (1991) 0.86
Production and characterization of anti-idiotypic antibody reagents. Methods Enzymol (1989) 0.86
Quantitation of tumor foci in an experimental murine tumor model using computer-assisted video imaging. Anal Biochem (1998) 0.86
DNA vaccination strategies against infectious diseases. Int J Parasitol (1999) 0.86
Surgery on the paralyzed, unanesthetized newborn. Birth (1986) 0.85
Inhibition of lymphokine-activated killer activity during HIV infection: role of HIV-1 gp41 synthetic peptides. Nat Immun Cell Growth Regul (1990) 0.85
Anti-idiotypic antibody response to monoclonal anti-CD4 preparations in nonhuman primate species. J Immunol (1991) 0.85
When perinatal caregivers enter the insurance business. Birth (1986) 0.85
Structural characterization of a cross-reactive idiotype shared by monoclonal antibodies specific for the human CD4 molecule. J Biol Chem (1991) 0.85